Beta-Tricalcium Phosphate and Concentrated Growth Factors in Treatment of Intra-bony Defect Randomized Clinical Trial
RCT
Biodegradable Gelatin Sponge Loaded With Beta-Tricalcium Phosphate Sponges Incorporating Concentrated Growth Factors in the Treatment of Intra-bony Pocket Randomized Clinical and Radiographic Study
1 other identifier
interventional
40
1 country
1
Brief Summary
This clinical study aimed to evaluate the efficacy of biodegradable gelatin sponge loaded with Beta-tricalcium phosphate socked in concentrated growth factors in the treatment of periodontal intra-bony defects, as compared with biodegradable gelatin/beta-tricalcium phosphate sponges alone.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_2
Started Jan 2021
Shorter than P25 for phase_2
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 31, 2020
CompletedStudy Start
First participant enrolled
January 1, 2021
CompletedFirst Posted
Study publicly available on registry
January 6, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2021
CompletedOctober 4, 2021
October 1, 2021
6 months
December 31, 2020
October 1, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (6)
gingival index
gingival index will be recorded at baseline, 3, and 6 months at the site to be treated
6months
bleeding on probing
bleeding on probing will be recorded at baseline, 3, and 6 months at the site to be treated
6 months
probing pocket depth
probing pocket depth will be recorded at baseline, 3, and 6 months at the site to be treated
6 months
clinical attachment level
clinical attachment level will be recorded at baseline, 3, and 6 months at the site to be treated
6 months
cone beam x ray measuring defect area
defect area will be recorded at baseline, and 6 months at the site to be treated
6 months
cone beam x ray measuring bone density
bone density will be recorded at baseline, and 6 months at the site to be treated
6 months
Study Arms (2)
beta-tricalcium phosphate plus concentrated growth factors
EXPERIMENTALsurgery plus biodegradable gelatin sponge loaded with Beta-tricalcium phosphate socked in concentrated growth factors (test group).
beta tricalcium phosphate alone(control group)
PLACEBO COMPARATORsurgery plus biodegradable gelatin/beta-tricalcium phosphate sponges alone. (control group),
Interventions
Open flap for removal of diseased periodontal tissues and necrotic cementum
use of Biodegradable Gelatin Sponge loaded with Beta-tricalcium Phosphate incorporating Concentrated Growth Factors in Periodontal Defect
use of Biodegradable Gelatin Sponge loaded with Beta-tricalcium Phosphate alone in the Intrabony Periodontal Defect
Eligibility Criteria
You may qualify if:
- systemically healthy patients were selected
- patients who had not received any medications for the previous six months that may interfere with periodontal tissue health or healing.
- Patients should demonstrate their ability to maintain good oral hygiene
You may not qualify if:
- Smokers and pregnant patients.
- Medically compromised patients and systemic conditions precluding periodontal surgery.
- Subjects who do not comply with oral hygiene measures as evidenced in recall visits.
- Sites with tooth mobility
- Restoration or caries in the site to be treated or non-vital tooth
- Restoration or caries in the site to be treated or non-vital tooth
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Tanta Universitylead
Study Sites (1)
Malak Mohamed Shoukheba
Tanta, 020, Egypt
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
malak m shoukheba
Cairo University
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- associate prof.
Study Record Dates
First Submitted
December 31, 2020
First Posted
January 6, 2021
Study Start
January 1, 2021
Primary Completion
July 1, 2021
Study Completion
July 1, 2021
Last Updated
October 4, 2021
Record last verified: 2021-10
Data Sharing
- IPD Sharing
- Will not share